Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1967 1
1972 1
1986 1
1990 1
1992 1
1993 2
1994 2
1995 2
1996 2
1997 1
1998 1
2001 3
2002 2
2003 1
2004 5
2005 5
2006 2
2007 1
2008 2
2009 1
2010 5
2011 2
2012 1
2013 6
2014 1
2015 2
2016 4
2017 7
2018 7
2019 4
2020 8
2021 21
2022 16
2023 9
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
i2b2 implemented over SMART-on-FHIR.
Paris N, Mendis M, Daniel C, Murphy S, Tannier X, Zweigenbaum P. Paris N, et al. AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:369-378. eCollection 2018. AMIA Jt Summits Transl Sci Proc. 2018. PMID: 29888095 Free PMC article.
Risks of early mortality and pulmonary complications following surgery in patients with COVID-19.
Khonsari RH, Bernaux M, Vie JJ, Diallo A, Paris N, Luong LB, Assouad J, Paugam C, Simon T, Vicaut E, Nizard R, Vibert E; AP-HP/Universities/INSERM COVID-19 research collaboration, AP-HP COVID Clinical Data Warehouse initiative. Khonsari RH, et al. Among authors: paris n. Br J Surg. 2021 Apr 30;108(4):e158-e159. doi: 10.1093/bjs/znab007. Br J Surg. 2021. PMID: 33793755 Free PMC article. No abstract available.
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium.
Sperotto F, Gutiérrez-Sacristán A, Makwana S, Li X, Rofeberg VN, Cai T, Bourgeois FT, Omenn GS, Hanauer DA, Sáez C, Bonzel CL, Bucholz E, Dionne A, Elias MD, García-Barrio N, González TG, Issitt RW, Kernan KF, Laird-Gion J, Maidlow SE, Mandl KD, Ahooyi TM, Moraleda C, Morris M, Moshal KL, Pedrera-Jiménez M, Shah MA, South AM, Spiridou A, Taylor DM, Verdy G, Visweswaran S, Wang X, Xia Z, Zachariasse JM; Consortium for Clinical Characterization of COVID-19 by EHR (4CE); Newburger JW, Avillach P. Sperotto F, et al. EClinicalMedicine. 2023 Sep 14;64:102212. doi: 10.1016/j.eclinm.2023.102212. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37745025 Free PMC article.
Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.
Burgel PR, Paillasseur JL, Durieu I, Reynaud-Gaubert M, Hamidfar R, Murris-Espin M, Danner-Boucher I, Chiron R, Leroy S, Douvry B, Grenet D, Mely L, Ramel S, Montcouquiol S, Burnet E, Ouaalaya EH, Sogni P, Da Silva J, Martin C; Participating Investigators of the French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Ann Am Thorac Soc. 2024 Jul;21(7):1053-1064. doi: 10.1513/AnnalsATS.202312-1065OC. Ann Am Thorac Soc. 2024. PMID: 38579175
Potential pitfalls in the use of real-world data for studying long COVID.
Zhang HG, Honerlaw JP, Maripuri M, Samayamuthu MJ, Beaulieu-Jones BR, Baig HS, L'Yi S, Ho YL, Morris M, Panickan VA, Wang X, Weber GM, Liao KP, Visweswaran S, Tan BWQ, Yuan W, Gehlenborg N, Muralidhar S, Ramoni RB; Consortium for Clinical Characterization of COVID-19 by EHR (4CE); Kohane IS, Xia Z, Cho K, Cai T, Brat GA. Zhang HG, et al. Nat Med. 2023 May;29(5):1040-1043. doi: 10.1038/s41591-023-02274-y. Nat Med. 2023. PMID: 37055567 Free PMC article. No abstract available.
Paradoxical reactions and biologic agents: a French cohort study of 9303 patients.
Bataille P, Layese R, Claudepierre P, Paris N, Dubiel J, Amiot A, Sbidian E; AP-HP/Universities/Inserm COVID-19 research collaboration and on behalf of the ‘Entrepôt de Données de Santé’ AP-HP consortium. Bataille P, et al. Among authors: paris n. Br J Dermatol. 2022 Nov;187(5):676-683. doi: 10.1111/bjd.21716. Epub 2022 Jul 12. Br J Dermatol. 2022. PMID: 35770735
Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Burgel PR, Durieu I, Chiron R, Ramel S, Danner-Boucher I, Prevotat A, Grenet D, Marguet C, Reynaud-Gaubert M, Macey J, Mely L, Fanton A, Quetant S, Lemonnier L, Paillasseur JL, Da Silva J, Martin C; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Am J Respir Crit Care Med. 2021 Jul 1;204(1):64-73. doi: 10.1164/rccm.202011-4153OC. Am J Respir Crit Care Med. 2021. PMID: 33600738
125 results